Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma

小梁切除术 医学 眼压 眼科 青光眼 开角型青光眼 丝裂霉素C 假性白内障 危险系数 回顾性队列研究 比例危险模型 青光眼手术 外科 视力 内科学 置信区间
作者
Daisuke Tanaka,Hideo Nakanishi,Masanori Hangai,Tadamichi Akagi,Shigenori Morooka,Hanako Ohashi Ikeda,Nagahisa Yoshimura
出处
期刊:Japanese Journal of Ophthalmology 卷期号:60 (6): 446-453 被引量:17
标识
DOI:10.1007/s10384-016-0468-7
摘要

To determine the clinical characteristics and surgical outcomes of highly myopic (HM) eyes with an axial length (AL) of ≥26.0 mm that underwent trabeculectomy with mitomycin C (MMC). This was a retrospective study of 63 eyes of 54 patients with primary open-angle glaucoma that underwent trabeculectomy with MMC. The characteristics and surgical outcomes of 19 HM eyes were compared with those of 44 non-HM eyes. Surgical success was defined as an high intraocular pressure (IOP) of ≤21 mmHg (criterion A), ≤18 mmHg (criterion B), or ≤15 mmHg (criterion C), with a lower IOP cutoff of 6 mmHg and a >20 % reduction regardless of the use of antiglaucoma medication. Cox regression analyses were performed to evaluate the effect of each pretreatment and surgical factor on the success rate. Patients with HM eyes were significantly younger than those with non-HM eyes (mean age 64.1 ± 9.9 vs. 69.1 ± 9.5 years; P < 0.05). The 3-year qualified success rates for HM eyes and non-HM eyes did not differ significantly for the three criteria. Younger age [hazard ratio (HR) for a 1-year increase 0.93, P < 0.005], preoperative pseudophakia (HR 3.88, P < 0.005), and shorter AL (HR for a 1-mm increase 0.72, P < 0.05) were found to be significant risk factors for trabeculectomy failure based on an IOP of ≤15 mmHg (criterion C). Age and pseudophakia also had significant effects on trabeculectomy failure based on criteria A and B, and the AL had a significant influence based on criterion A. In our patient cohort a longer AL was not a risk factor for trabeculectomy failure, but it may be a success factor for trabeculectomy with MMC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
2秒前
2秒前
科研通AI2S应助好玩和有趣采纳,获得10
2秒前
美丽跳跳糖完成签到,获得积分20
2秒前
2秒前
丘比特应助llll采纳,获得10
3秒前
3秒前
迟大猫应助su采纳,获得10
3秒前
发嗲的戎完成签到 ,获得积分10
4秒前
4秒前
内向凌兰完成签到,获得积分10
4秒前
4秒前
zhappy完成签到,获得积分10
5秒前
satchzhao发布了新的文献求助10
5秒前
友好的妍完成签到 ,获得积分10
6秒前
香山叶正红完成签到 ,获得积分10
7秒前
TOM发布了新的文献求助10
7秒前
沙耶酱完成签到,获得积分10
7秒前
赢赢发布了新的文献求助10
8秒前
9秒前
尺素寸心完成签到,获得积分10
10秒前
11秒前
老实不尤完成签到,获得积分10
12秒前
CCL应助mammoth采纳,获得40
13秒前
14秒前
14秒前
15秒前
16秒前
盘尼西林给盘尼西林的求助进行了留言
16秒前
16秒前
香蕉觅云应助XXF采纳,获得10
16秒前
17秒前
大个应助招财不肥采纳,获得10
17秒前
xx发布了新的文献求助10
18秒前
joanna0932完成签到,获得积分10
18秒前
坚定亦竹完成签到,获得积分10
19秒前
mia完成签到,获得积分20
19秒前
19秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808